Compare NVX & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVX | BDSX |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | Australia | United States |
| Employees | 192 | N/A |
| Industry | Industrial Machinery/Components | Precision Instruments |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 144.3M | 122.0M |
| IPO Year | N/A | 2020 |
| Metric | NVX | BDSX |
|---|---|---|
| Price | $0.70 | $13.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $32.50 |
| AVG Volume (30 Days) | ★ 378.9K | 68.9K |
| Earning Date | 04-23-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $88,499,000.00 |
| Revenue This Year | $3,904.19 | $25.26 |
| Revenue Next Year | $91.72 | $19.70 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 24.08 |
| 52 Week Low | $0.61 | $0.25 |
| 52 Week High | $3.86 | $20.21 |
| Indicator | NVX | BDSX |
|---|---|---|
| Relative Strength Index (RSI) | 45.33 | 41.08 |
| Support Level | $0.63 | $13.41 |
| Resistance Level | $0.81 | $20.21 |
| Average True Range (ATR) | 0.05 | 1.21 |
| MACD | 0.01 | -0.31 |
| Stochastic Oscillator | 50.69 | 9.14 |
NOVONIX Ltd is a battery technology company developing and scaling materials and equipment critical to the lithium-ion battery supply chain. The company has three operating segments: Battery Materials: It develops and manufactures battery anode materials, ii) Battery Technology: It develops and manufactures battery cell testing equipment, performs consulting services and carries out research and development in battery development, and Graphite Exploration: It manages the maintenance and future development of Mount Dromedary natural graphite deposit. The majority of the company's revenue is derived from the Battery Technology segment. Geographically, the maximum revenue is derived from North America, followed by Asia, and Europe.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.